Document is current
Any future updates will be listed below
-
Authors
Helmer, Philipp
Hottenrott, Sebastian
Wienböker, Kathrin
Brugger, Jürgen
Stoppe, Christian
Schmid, Benedikt
Kranke, Peter
Meybohm, Patrick
Sammeth, Michael
-
Funding
Funding for this research was provided by:
Vogel-Stiftung Würzburg
IZKF Würzburg
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 19 October 2024
Accepted: 14 February 2025
First Online: 6 March 2025
Declaration
:
: SH, KW, JB, BS, and MS declare no conflicts of interest. PH received a research award from Vogel-Foundation and is a member of the Clinician Scientist Programme, Wuerzburg. PM received honoraria for scientific lectures from CSL Behring GmbH, Pharmacosmos GmbH, and CSL Vifor GmbH. PK received lecturing fees from TEVA, Sintetica, CSL Behring GmbH, Senzyme, Vifor Pharma GmbH, Pharmacosmos, and Grünenthal and consulted for TEVA, Milestone Scientific Inc, Sintetica and Amicus Ltd. CS received honoraria for scientific lectures and consulting fees from BBRAUN; Fresenius and Abiomed. All mentioned funders and especially the manufacturers of the investigated devices had no role in the design of the study; collection, analyses, or interpretation of data; writing of the manuscript; or in the decision to publish the results.
: The ethics committee of the University of Würzburg in Germany approved the study protocol prior to the recruitment of the trial (Ref. No. 145/21_c).
